IXJ icon

iShares Global Healthcare ETF

87.85 USD
+0.22
0.25%
At close Updated Sep 18, 4:00 PM EDT
1 day
0.25%
5 days
-0.96%
1 month
1%
3 months
3.5%
6 months
-5.01%
Year to date
2.14%
1 year
-11.28%
5 years
21.31%
10 years
67.75%
0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

16% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 32

0.64% more ownership

Funds ownership: 73.37% [Q1] → 74.01% (+0.64%) [Q2]

0% more funds holding

Funds holding: 263 [Q1] → 264 (+1) [Q2]

4% less capital invested

Capital invested by funds: $2.9B [Q1] → $2.78B (-$123M) [Q2]

11% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 83

Financial journalist opinion

Negative
Seeking Alpha
1 month ago
On IXJ, A Contradiction Has Emerged That Is Too Big To Be Ignored
Tough moment for healthcare: low momentum, high volatility, and downgraded EPS. It is evident when looking at the IXJ ETF, focused on global healthcare: 70% US, 30% international. But relative valuations have remained attractive: healthcare trades at a forward P/E in the 30th percentile of the past 30 years' distribution.
On IXJ, A Contradiction Has Emerged That Is Too Big To Be Ignored
Positive
Seeking Alpha
1 month ago
IXJ: A Bet On Global Healthcare Recovery
IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs for a more balanced risk/reward profile. The fund's heavy allocation to pharmaceuticals and biotechnology targets high-growth areas like obesity drugs, oncology, and AI-driven healthcare equipment. Despite a higher expense ratio and currency/regulatory risks, IXJ's global diversification and defensive sector positioning justify its buy rating.
IXJ: A Bet On Global Healthcare Recovery
Neutral
Seeking Alpha
3 months ago
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Positive
Seeking Alpha
4 months ago
IXJ: Healthcare Sector Dashboard For May
This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Healthcare providers and pharmaceuticals/biotechnology are the most compelling subsectors based on value and quality scores. IXJ ETF offers global healthcare exposure but remains concentrated in U.S. stocks and top holdings; it has trailed XLV in long-term returns but is more diversified.
IXJ: Healthcare Sector Dashboard For May
Negative
Zacks Investment Research
6 months ago
Recession Fears Looming? Secure Your Portfolio With These ETFs
Look at ETFs to safeguard your portfolio as declining consumer confidence, sluggish growth and persistent inflationary pressures increase the likelihood of the U.S. economy slipping into a recession in 2025.
Recession Fears Looming? Secure Your Portfolio With These ETFs
Neutral
Seeking Alpha
6 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Negative
Seeking Alpha
7 months ago
IXJ: Healthcare Sector Dashboard For February
This article provides a top-down analysis of the healthcare sector, focusing on fundamental and momentum metrics. The healthcare sector is currently overvalued by about 13% relative to 11-year averages, with pharmaceuticals/biotechnology being the most overvalued. IXJ offers global healthcare exposure but is heavily weighted in U.S. companies and has underperformed XLV for 10 years.
IXJ: Healthcare Sector Dashboard For February
Neutral
Zacks Investment Research
9 months ago
2025 Market Uncertainty? ETFs to Steady Your Portfolio
With escalating geopolitical tensions and unfavorable inflation trends in the U.S., increasing exposure to defensive sectors emerges as a smart investment strategy to navigate the potentially uncertain economic landscape of 2025.
2025 Market Uncertainty? ETFs to Steady Your Portfolio
Negative
Seeking Alpha
10 months ago
IXJ: Healthcare Sector Dashboard For November
The healthcare sector is overvalued by 18% relative to 11-year averages, with pharmaceuticals/biotechnology and healthcare equipment most overpriced. IXJ offers global healthcare exposure with lower concentration in top holdings compared to XLV, but still has 72% of assets in U.S. companies. 10 stocks cheaper than their peers in November.
IXJ: Healthcare Sector Dashboard For November
Negative
Seeking Alpha
1 year ago
IXJ: Healthcare Sector Dashboard For August
Monthly article series showing healthcare industry metrics. The healthcare sector is overvalued by about 18% relative to 11-year averages. The most overvalued subsector is pharmaceuticals and biotechnology.
IXJ: Healthcare Sector Dashboard For August
Charts implemented using Lightweight Charts™